NOVTTechnology · Scientific & Technical InstrumentsThe 3 Wall Street analysts covering Novanta, Inc. hold a median 12-month price target of $195 — +16.8% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 55 of 100 as at 15 Aug 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores Novanta, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Revisions (99): Analysts have, on balance, been raising their forecasts.
Volatility (23): The share price moves around a lot.
Size (21): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on NOVT, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +16.8% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 13 May 2026 | Baird | Maintains | Outperform | $144 → $173 |
| 30 Mar 2026 | Baird | Upgrade | Outperform | — |
| 11 Aug 2025 | Baird | Maintains | Neutral | — |
| 3 Mar 2025 | Baird | Maintains | Neutral | — |
| 6 Nov 2024 | Baird | Maintains | Neutral | — |
| 7 Aug 2024 | Baird | Maintains | Neutral | — |
| 11 May 2023 | Baird | Maintains | Neutral | — |
| 11 May 2022 | William Blair | Upgrade | Outperform | — |
| 13 Nov 2020 | Berenberg | Initiates | Hold | — |
| 13 May 2020 | Baird | Maintains | Neutral | — |
| 28 Feb 2019 | Baird | Maintains | Neutral | — |
| 9 May 2018 | Baird | Downgrade | Neutral | — |
| 27 Feb 2018 | William Blair | Initiates | Outperform | — |
| 8 Dec 2017 | Baird | Initiates | Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. NOVT appears on the weeks it earns a place.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 7% of US stocks
Cheaper than 22% of US stocks
Cheaper than 28% of US stocks
Cheaper than 8% of US stocks
Higher than 53% of US stocks
Higher than 89% of US stocks
Higher than 57% of US stocks
Higher than 66% of US stocks
Higher than 62% of US stocks
Higher than 54% of US stocks
Higher than 71% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Novanta, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Zacks Investment Research published a piece examining whether Novanta (NOVT) has the attributes to be a top pick for momentum investors.
Why it matters — A positive momentum assessment from a major research firm could influence how investors perceive NOVT's near-term trading prospects.
Novanta reported second-quarter results featuring 9% organic sales growth, expanding margins, and higher operating cash flow. The company raised its full-year outlook following the late-July closing of its Riverpoint Medical acquisition.
Why it matters — NOVT watchers would note the strengthened growth and profitability momentum, reinforced by the completed Riverpoint Medical acquisition and an upwardly revised full-year outlook.
Seeking Alpha published the transcript of Novanta Inc.'s Q2 2026 earnings call, providing a record of management's discussion of results for the quarter. The item consists of the full earnings call transcript for the period.
Why it matters — The earnings call transcript gives NOVT investors direct insight into the company's Q2 2026 performance and management commentary.
Novanta reported quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.83 per share and surpassing the $0.76 per share it earned a year earlier. The results exceeded both earnings and revenue estimates.
Why it matters — Novanta watchers would care because the company delivered quarterly results above analyst expectations, including improved earnings versus the prior year.
Novanta reported its second quarter 2026 financial results, with revenue of $265.8 million, operating income of $18.1 million, net income of $12.5 million, and diluted EPS of $0.30. These figures compare with revenue of $241.0 million, operating income of $14.9 million, net income of $4.5 million, and diluted EPS of $0.12 in the same quarter of 2025.
Why it matters — The results show year-over-year growth across revenue, operating income, net income, and earnings per share, providing NOVT watchers with a clear view of the company's latest quarterly performance.
The 3 Wall Street analysts covering Novanta, Inc. have a median 12-month price target of $195, with estimates ranging from $194 to $195. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 3 analysts covering Novanta, Inc., 3 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Novanta, Inc. 55 out of 100 across roughly 4,600 US stocks as at 15 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 15 Aug 2026, Novanta, Inc. ranks 55 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (99 of 100).
No one can know that. What the data says: the median 12-month target from 3 analysts implies +16.8% from the last close, and Ticker Nerd's factor model ranks Novanta, Inc. 55 out of 100 as at 15 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Novanta, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NOVT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $194 to $195 over the next 12 months.
Novanta, Inc. returned +41.0% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Novanta Inc. is a leading technology company that designs, manufactures, and sells precision photonic and motion control components and subsystems.
The most recent item we track (Zacks Investment Research, 12 Aug 2026): "Are You Looking for a Top Momentum Pick? Why Novanta (NOVT) is a Great Choice". Zacks Investment Research published a piece examining whether Novanta (NOVT) has the attributes to be a top pick for momentum investors.
Novanta Inc. is a leading technology company that designs, manufactures, and sells precision photonic and motion control components and subsystems. These products are integral to a variety of industries, including healthcare, industrial, and advanced technologies. Novanta's offerings include engineered components like lasers, beam delivery subsystems, and industrial solutions that enhance the precision and quality of production processes. The company leverages its technological expertise to provide solutions in applications such as minimally invasive surgery, medical diagnostics, and robotics. Novanta Inc. distinguishes itself through its innovation-driven approach and commitment to quality, ensuring its products meet stringent industry standards. Based in Bedford, Massachusetts, Novanta maintains a global footprint, with operations in numerous countries, allowing it to serve a diverse, international clientele. Its strategic role in enabling sophisticated manufacturing processes underscores its significance in the financial market as a valued industrial and technological partner.
CEO Mr. Matthijs Glastra · 3,000 employees · United States · https://www.novanta.com